QSS
EPZM

Quantitative Systematic Strategies’s Epizyme, Inc EPZM Stock Holding History

Quantitative Systematic Strategies’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,989
Closed -$188K – 613
2019
Q2 		$188K Buy
+14,989
New +$193K 0.04% 417
2019
Q1 		– Sell
-38,402
Closed -$237K – 713
2018
Q4 		$237K Buy
38,402
+23,741
+162% +$181K 0.05% 482
2018
Q3 		$155K Buy
+14,661
New +$167K 0.03% 548
2015
Q3 		– Sell
-23,960
Closed -$535K – 562
2015
Q2 		$535K Sell
23,960
-1,752
-7% -$33.7K 0.12% 302
2015
Q1 		$503K Buy
+25,712
New +$531K 0.14% 199

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Quantitative Systematic Strategies's EPZM Position: Q3 2019 in Review

Quantitative Systematic Strategies sold out of Epizyme, Inc (EPZM) in Q3 2019, closing a stake of 14,989 shares — an estimated $188K sold.

Quantitative Systematic Strategies first reported a position in EPZM in Q1 2015 and held it in 5 quarters. The position peaked at $535K in Q2 2015. 115 funds tracked by Wall St. Rank hold EPZM as of Q3 2019.

  • Quantitative Systematic Strategies reported no remaining Epizyme, Inc position as of Q3 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,989 Epizyme, Inc shares in Q3 2019, an estimated $188K.
  • Quantitative Systematic Strategies first reported a position in Epizyme, Inc in Q1 2015 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Epizyme, Inc position peaked at $535K in Q2 2015.
  • 115 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2019, filed 7 Nov 2019.